Insider · CIK 0001724346
Michael Kaseta
Files at HRTX (HERON THERAPEUTICS, INC. /DE/), LQDA (Liquidia Corp). First filing Oct 15, 2024, latest Dec 2, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LQDA: Liquidia Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Liquidia Corp | $38k 1,166 shares | -0% | +203% from low-2% from high | |
| 15Weak | Liquidia Corp | $272k 11,630 shares | -3% | +142% from low-19% from high | |
| 8Weak | Liquidia Corp | $33k 1,148 shares | -0% | +194% from low0% from high | |
| 35Weak | Liquidia Corp | $524k 20,000 shares | -5% | +167% from low-1% from high | |
| 36Weak | Liquidia Corp | $600k 30,000 shares | -7% | +106% from low0% from high | |
| 13Weak | Liquidia Corp | $165k 11,580 shares | -3% | +49% from low-25% from high | |
| 15Weak | Liquidia Corp | $251k 14,777 shares | -3% | +81% from low-9% from high | |
| 2Weak | Liquidia Corp | $14k 859 shares | -0% | +74% from low-13% from high | |
| 27Weak | Liquidia Corp | $112k 8,283 shares | -2% | +42% from low-16% from high | |
| 0Weak | Liquidia Corp | $14k 874 shares | -0% | +53% from low-10% from high | |
| 31Weak | Liquidia Corp | $275k 23,370 shares | -5% | +17% from low-9% from high | |
| 2Weak | Liquidia Corp | $13k 1,091 shares | -0% | - | |
| 23Weak | Liquidia Corp | $43k 3,892 shares | -1% | +15% from low-0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +2,343 | - | - | 354,989 | Dec 2, 2025 |
| Dec 1, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -1,166 | $32.19 | $38k | 353,823 | Dec 2, 2025 |
| Nov 28, 2025 | LQDA Liquidia Corp | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,343 | $0.00 | $0 | 2,344 | Dec 2, 2025 |
| Oct 10, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +5,828 | - | - | 364,276 | Oct 15, 2025 |
| Oct 13, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -11,630 | $23.41 | $272k | 352,646 | Oct 15, 2025 |
| Oct 10, 2025 | LQDA Liquidia Corp | MOption exercise Performance Stock Unitderivative10b5-1 | -5,828 | $0.00 | $0 | 52,453 | Oct 15, 2025 |
| Aug 29, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 359,596 | Sep 3, 2025 |
| Sep 2, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -1,148 | $29.05 | $33k | 358,448 | Sep 3, 2025 |
| Aug 31, 2025 | LQDA Liquidia Corp | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,344 | $0.00 | $0 | 4,687 | Sep 3, 2025 |
| Aug 15, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -20,000 | $26.18 | $524k | 356,412 | Aug 19, 2025 |
| Aug 5, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -30,000 | $20.00 | $600k | 376,412 | Aug 7, 2025 |
| Jul 11, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +5,828 | - | - | 417,992 | Jul 15, 2025 |
| Jul 14, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -11,580 | $14.28 | $165k | 406,412 | Jul 15, 2025 |
| Jul 11, 2025 | LQDA Liquidia Corp | MOption exercise Performance Stock Unitsderivative10b5-1 | -5,828 | $0.00 | $0 | 58,281 | Jul 15, 2025 |
| Jun 3, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +29,141 | - | - | 426,941 | Jun 5, 2025 |
| Jun 4, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -14,777 | $16.97 | $251k | 412,164 | Jun 5, 2025 |
| Jun 3, 2025 | LQDA Liquidia Corp | MOption exercise Performance Stock Unitsderivative10b5-1 | -29,141 | $0.00 | $0 | 64,109 | Jun 5, 2025 |
| May 30, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 398,659 | Jun 3, 2025 |
| Jun 2, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -859 | $16.74 | $14k | 397,800 | Jun 3, 2025 |
| May 30, 2025 | LQDA Liquidia Corp | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,344 | $0.00 | $0 | 7,031 | Jun 3, 2025 |
| Apr 14, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -8,283 | $13.57 | $112k | 396,315 | Apr 16, 2025 |
| Feb 28, 2025 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +2,344 | - | - | 405,472 | Mar 4, 2025 |
| Mar 3, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -874 | $15.45 | $14k | 404,598 | Mar 4, 2025 |
| Feb 28, 2025 | LQDA Liquidia Corp | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,344 | $0.00 | $0 | 9,375 | Mar 4, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +17,950 | $0.00 | $0 | 55,829 | Feb 3, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +35,900 | $1.73 | $62k | 35,900 | Feb 3, 2025 |
| Jan 11, 2025 | LQDA Liquidia Corp | AGrant or award Common Stock10b5-1 | +112,797 | $0.00 | $0 | 425,125 | Jan 14, 2025 |
| Jan 14, 2025 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -23,370 | $11.78 | $275k | 401,755 | Jan 14, 2025 |
| Jan 11, 2025 | LQDA Liquidia Corp | AGrant or award Performance Stock Unitsderivative10b5-1 | +112,797 | $0.00 | $0 | 112,797 | Jan 14, 2025 |
| Nov 30, 2024 | LQDA Liquidia Corp | MOption exercise Common Stock10b5-1 | +2,343 | - | - | 313,419 | Dec 3, 2024 |
| Dec 2, 2024 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -1,091 | $11.51 | $13k | 312,328 | Dec 3, 2024 |
| Nov 30, 2024 | LQDA Liquidia Corp | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,343 | $0.00 | $0 | 11,719 | Dec 3, 2024 |
| Nov 4, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +37,879 | - | - | 37,879 | Nov 6, 2024 |
| Nov 4, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +227,272 | $1.78 | $405k | 227,272 | Nov 6, 2024 |
| Oct 14, 2024 | LQDA Liquidia Corp | SOpen-market sale Common Stock10b5-1 | -3,892 | $11.11 | $43k | 311,076 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.